MD950010A - Compoziţie pentru înlăturarea sau dezactivarea componentelor dăunătoare în sînge sau alte lichide extracelulare ale organismului şi procedeu de obţinere - Google Patents

Compoziţie pentru înlăturarea sau dezactivarea componentelor dăunătoare în sînge sau alte lichide extracelulare ale organismului şi procedeu de obţinere

Info

Publication number
MD950010A
MD950010A MD95-0010A MD950010A MD950010A MD 950010 A MD950010 A MD 950010A MD 950010 A MD950010 A MD 950010A MD 950010 A MD950010 A MD 950010A
Authority
MD
Moldova
Prior art keywords
composition
blood
preparation
body fluids
harmful components
Prior art date
Application number
MD95-0010A
Other languages
English (en)
Russian (ru)
Inventor
Henry Marinus Christensen
Hans Berg Andreasen
Original Assignee
A/S Af 18. Juni 1990
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A/S Af 18. Juni 1990 filed Critical A/S Af 18. Juni 1990
Publication of MD950010A publication Critical patent/MD950010A/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
    • B01J20/3206—Organic carriers, supports or substrates
    • B01J20/3208—Polymeric carriers, supports or substrates
    • B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
    • B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
    • B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
    • B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B01J20/3253—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising a cyclic structure not containing any of the heteroatoms nitrogen, oxygen or sulfur, e.g. aromatic structures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B01J20/3255—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising a cyclic structure containing at least one of the heteroatoms nitrogen, oxygen or sulfur, e.g. heterocyclic or heteroaromatic structures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
    • B01J2220/48—Sorbents characterised by the starting material used for their preparation
    • B01J2220/4812—Sorbents characterised by the starting material used for their preparation the starting material being of organic character
    • B01J2220/4825—Polysaccharides or cellulose materials, e.g. starch, chitin, sawdust, wood, straw, cotton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Invenţia se referă la compoziţia pentru înlăturarea sau dezactivarea componentelor dăunătoare, inclusiv a viruşilor, din sânge sau alte lichide extracelulare ale organismului omului sau animalelor. Compoziţia menţionată conţine un compus grown-eteric, substituit pe polizaharidă, de preferinţă, pe dextran. Compoziţia propusă poate fi solubilă în apă şi dă posibilitatea preparării injecţiilor intravenoase sau insolubilă în apă şi se poate folosi pentru prelucrare extracorporală. Se propune şi un procedeu de obţinere a grown-eterilor substituiţi pe dextran.
MD95-0010A 1989-06-14 1990-06-14 Compoziţie pentru înlăturarea sau dezactivarea componentelor dăunătoare în sînge sau alte lichide extracelulare ale organismului şi procedeu de obţinere MD950010A (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK291389A DK169306B1 (da) 1989-06-14 1989-06-14 Middel til fjernelse eller inaktivering af uønskede komponenter i blod eller andre ekstracellulære legemsvæsker samt fremgangsmåde til fremstilling af dextran-O-carbonyl-benzo-18-crown-6 og af dextran-hydroxyethylbenzo-18-crown-6
PCT/DK1990/000151 WO1990015610A1 (en) 1989-06-14 1990-06-14 A composition for removing or inactivating harmful components in blood or other extracellular body fluids

Publications (1)

Publication Number Publication Date
MD950010A true MD950010A (ro) 1996-05-31

Family

ID=8117054

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0010A MD950010A (ro) 1989-06-14 1990-06-14 Compoziţie pentru înlăturarea sau dezactivarea componentelor dăunătoare în sînge sau alte lichide extracelulare ale organismului şi procedeu de obţinere

Country Status (21)

Country Link
US (2) US5314878A (ro)
EP (1) EP0481013B1 (ro)
JP (1) JPH04506211A (ro)
KR (1) KR920702624A (ro)
AT (1) ATE111739T1 (ro)
AU (1) AU635464B2 (ro)
BG (1) BG60089B2 (ro)
CA (1) CA2058442A1 (ro)
DE (1) DE69012818T2 (ro)
DK (2) DK169306B1 (ro)
ES (1) ES2062571T3 (ro)
FI (1) FI95139C (ro)
HU (1) HU208083B (ro)
IE (1) IE62998B1 (ro)
IL (1) IL94712A (ro)
MD (1) MD950010A (ro)
NO (1) NO914854L (ro)
NZ (1) NZ234034A (ro)
OA (1) OA09646A (ro)
WO (1) WO1990015610A1 (ro)
ZA (1) ZA904546B (ro)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68901924T2 (de) * 1988-01-26 1992-12-10 Nycomed As Paramagnetische verbindungen.
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
GB201506663D0 (en) * 2015-04-20 2015-06-03 Komplexis S R L In-vivo delivery of ion chelating ligands for therapy

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113739A (en) * 1974-01-28 1978-09-12 The Dow Chemical Company Process for preparation of (poly)cyclic polyethers
US3965116A (en) * 1974-09-12 1976-06-22 The Regents Of The University Of California Multioxymacrocycles
US4024158A (en) * 1975-09-19 1977-05-17 E. I. Du Pont De Nemours And Company Aroylcrownethers
US3997565A (en) * 1975-09-19 1976-12-14 E. I. Du Pont De Nemours And Company Acylcrownether oximes and oxime ethers
US4474963A (en) * 1980-11-03 1984-10-02 W. R. Grace & Co. Crown ether compositions with sidearms affording enhanced cation binding
US4562272A (en) * 1981-03-27 1985-12-31 Union Carbide Corporation Process for preparing cyclic polyethers
HU187360B (en) * 1981-09-22 1985-12-28 Chinoin Gyogyszer Es Vegyeszet Komplex-forming cyclodextrine-crown-ether derivatives and process for producing them
US4436923A (en) * 1982-06-07 1984-03-13 The President And Trustees Of The Miami University Trifluoromethyl-substituted chromogenic crown ethers and methods of using same
JPS595180A (ja) * 1982-06-30 1984-01-12 Toshiyuki Shono ビスクラウンエ−テル誘導体とその用途
US4631119A (en) * 1983-11-23 1986-12-23 W. R. Grace & Co. Reversible, electrochemically-switched lariat ethers
US4767614A (en) * 1984-02-29 1988-08-30 Wm. Wrigley Jr. Company Modified dextrans in a dental health method deactivating glucosyltransferase enzymes
US4570004A (en) * 1984-04-06 1986-02-11 The Board Of Regents, University Of Texas System Perfluoro crown ethers
US4794000A (en) * 1987-01-08 1988-12-27 Synthetic Blood Corporation Coacervate-based oral delivery system for medically useful compositions
US4777270A (en) * 1985-01-25 1988-10-11 Pfizer Inc. Macrocyclic polyether carboxylic acids
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
IT1214708B (it) * 1986-08-01 1990-01-18 Medosan Ind Biochimi Impiego del dietilaminoetil-destrano (deae-d) come farmaco antidiabetico (diabete tipo i-ii-iii) e regolatore del metabolismo glucidico
GB8702569D0 (en) * 1987-02-05 1987-03-11 Nat Res Dev Moiety for selective separation
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
GB8719042D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere

Also Published As

Publication number Publication date
DE69012818T2 (de) 1995-03-30
EP0481013A1 (en) 1992-04-22
ZA904546B (en) 1991-04-24
BG60089B2 (bg) 1993-10-29
WO1990015610A1 (en) 1990-12-27
IE902131L (en) 1990-12-14
NO914854D0 (no) 1991-12-10
IE902131A1 (en) 1991-01-02
DK291389A (da) 1990-12-15
JPH04506211A (ja) 1992-10-29
CA2058442A1 (en) 1990-12-15
HU906647D0 (en) 1992-02-28
OA09646A (en) 1993-04-30
FI95139C (fi) 1995-12-27
US5514668A (en) 1996-05-07
US5314878A (en) 1994-05-24
DK291389D0 (da) 1989-06-14
DK169306B1 (da) 1994-10-10
HU208083B (en) 1993-08-30
DE69012818D1 (de) 1994-10-27
DK0481013T3 (da) 1995-04-10
ATE111739T1 (de) 1994-10-15
AU5940190A (en) 1991-01-08
HUT59011A (en) 1992-04-28
IE62998B1 (en) 1995-03-08
IL94712A (en) 1994-11-28
ES2062571T3 (es) 1994-12-16
KR920702624A (ko) 1992-10-06
NZ234034A (en) 1991-11-26
AU635464B2 (en) 1993-03-18
EP0481013B1 (en) 1994-09-21
FI915888A0 (fi) 1991-12-13
IL94712A0 (en) 1991-04-15
FI95139B (fi) 1995-09-15
NO914854L (no) 1991-12-10

Similar Documents

Publication Publication Date Title
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
ATE72406T1 (de) Vorrichtung zur applikation von implantaten.
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
DE69628844D1 (de) Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
EP0376251A3 (en) An anticoagulant substance obtained from urine
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
DE69610295D1 (de) Von einem retroviralen regulationsprotein abstammende, detoxifierte immunogene, dagegen gerichtete antikörper, verfahren zur deren herstellung und diese immunogene oder antikörper enthaltende, pharmazeutische zusammensetzungen.
NO913129L (no) Nytt trombolytisk middel.
ATE118351T1 (de) Wirkung von hormonen.
MD950010A (ro) Compoziţie pentru înlăturarea sau dezactivarea componentelor dăunătoare în sînge sau alte lichide extracelulare ale organismului şi procedeu de obţinere
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE59006307D1 (de) Badezusatz und dessen Verwendung.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
ATE137752T1 (de) 5-aminocarbonyl-5h-dibenzo-a,d>cyclohepten-5,10 imine zur behandlung von epilepsie und kokainsucht
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
BR9914792A (pt) Uso de agentes antifúngicos para tratamento deescleroses
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
RU93015924A (ru) Способ лечения трофических язв нижних конечностей
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
JPS6368527A (ja) Ｈｂ抗原不活化剤

Legal Events

Date Code Title Description
FA1A Withdrawn application

Free format text: 19980713